References
Lee YM, Kaplan MM: Primary sclerosing cholangitis. N Engl J Med 332:924-933, 1995
Gillberg R, Dotevall G, Ahren C: Chronic inflammatory bowel disease in patients with celiac disease. Scand J Gastroenterol 17:491-496, 1982
Hay JE, Weisner RH, Shorter RG, LaRusso NF, Baldus WP: Primary sclerosing cholangitis and celiac disease: A novel association. Ann Intern Med 109:713-717, 1988
Lewis HM, Goldin R, Leonard JN: Dermatitis herpetiformis and primary sclerosing cholangitis. Clin Exp Dermatol 18:363-365, 1993
Tysk C: Concurrent ulcerative colitis, celiac sprue, and primary sclerosing cholangitis. J Clin Gastroenterol 18:241-242, 1994
Lacaille F, Canioni D, Bernard O, Fabre M, Brousse N, Schmitz J: Celiac disease, inflammatory colitis, and primary sclerosing cholangitis in a girl with Turner's syndrome. J Pediatr Gastroenterol Nutr 21:463-467, 1995
Fracassetti O, Delvecchio G, Tambini R, Lorenzi N, Gavazzeni G: Primary sclerosing cholangitis with celiac sprue: two cases. J Clin Gastroenterol 22:71-80, 1996
Venturini I, Cosenza R, Miglioli L, Borghi A, Bagni A, Gandolfo M, Modonesi G, Zeneroli ML: Adult celiac disease and primary sclerosing cholangitis: two case reports. Hepatogastroenterolgy 45:2344-2347, 1998
Gow PJ, Fleming KA, Chapman RW: Primary sclerosing cholangitis associated with rheumatoid arthritis and HLA DR4: Is the association a marker of patients with progressive liver disease? J Hepatol 34:631-635, 2000
Kaukinen K, Halme L, Collin P, Farkkila M, Maki M, Vehmanen P, Partanen J, Hockerstedt K: Celiac disease in patients with severe liver disease: Gluten-free diet may reverse hepatic failure. Gastroenterology 122:881-888, 2002
Jacobsen MB, Fausa O, Elgjo K, Schrumpf E: Hepatic lesions in a dult celiac disease. Scand J Gastroenterol 25:656-662, 1990
Abdulkarim AS, Wiesner RH, Murray JA, Krause PK: Tissue transglutaminase antibodies are frequent in severe chronic liver disease with celiac disease associated HLA type. Gastroenterology 220:A179-A180, 2002 (abstr)
Snook JA, de silva HJ, Jewell DP: The association of autoimmune disorders with inflammatory bowel disease. QJM 72:835-840, 1989
Olsson R, Danielsson A, Jarnerot G, Lindstrom E, Loof L, Rolny P, Ryden BO, Tysk C, Wallerstedt S: Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 100:1319-1323, 1991
Chapman RW, Varghese Z, Gaul R, Patel G, Kokinon N, Sherlock S: Association of primary sclerosing cholangitis with HLA B8. Gut 24:38-41, 1983
Sollid LM, Thorsby E: HLA susceptibility genes in celiac disease: Genetic mapping and role in pathogenesis. Gastroenterology 105:910-922, 1993
Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, Ciusani E, Chapman R, Ercilla G, Fausa O, Knutsen I, Pares A, Rosina F, Olerup O, Thorsby E, Schrumpf E: HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 53:459-469, 1999
Prochazka EJ, Terasaki PI, Park MS, Goldstein LI, Busuttil RW: Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med 322:1842-1844, 1990
Zetterquist H, Broome U, Einarsson K, Oerlup O: HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: No HLA-DRw52a association in Swedish patients with sclerosing cholangitis. Gut 33:942-946, 1992
Park MS, Teraski PI: Inability to attribute susceptibility to primary sclerosing cholangitis to specific amino acid positions of the HLA-DRw52a allele [Letter]. N Engl J Med 325:1252, 1991
Schrumpf E: Association of primary sclerosing cholangitis and celiac disease: fact or fancy? Hepatology 10:1020-1021, 1989
Lanspa SJ, Chan ATH, Bell JS III, Go VLW, Dickson ER, DiMagno EP: pathogenesis of steatorrhea in primary biliary cirrhosis. Hepatology 5:837-842, 1985
Volta U, Bellentani S, Bianchi FB, Brandi G, De Franceschi L, Miglioli L, Granito A, Balli F, Tiribelli C: High prevalence of celiac disease in Italian general population. Dig Dis Sci 46:1500-1505, 2001
Cook HB, Burt MJ, Collett JA, Whitehead MR, Frampton CM, Chapman BA: Adult celiac disease: prevalence and clinical significance. J Gastroenterol Hepatol 15:1032-1036, 2000
Hovell CJ, Collett JA, Vautier G, Cheng AJP, Sutanto E, Mallon DF, Olynyk JK, Cullen DJE: High prevalence of celiac disease in a population-based study from Western Australia: a case for screening? Med J Aust 175:247-250, 2001
Rostami K, Mulder CJJ, Werre JM, van Beukelen FR, Kerchhaert J, Crusius JBA, Pena AS, Willekens FLA, Meijer JWR: High prevalence of celiac disease in apparently healthy blood donors suggests a high prevalence of undiagnosed celiac disease in the Dutch population. Scand J Gastroenterol 34:276-279, 1999
Hovdenak N, Hovild E, Aksnes L, Fluge G, Erichsen MM, Eide J: High prevalence of asymptomatic celiac disease in Norway: a study of blood donors. Eur J Gastroenterol Hepatol 11:185-187, 1999
Not T, Horvath K, Hill ID, Partanen J, Hammed A, Magazzu G, Fasano A: Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol 33:494-498, 1998
James MW, Scott BB: Celiac disease: The cause of the various associated disorders? Eur J Gastroenterol Hepatol 13:1119-1121, 2001
Parnell NDJ, Ciclitira PJ: Review article: Celiac disease and its management. Aliment Pharmacol Ther 13:1-13, 1999
Farrell RJ, Kelly CP: Celiac sprue. N Engl J Med 346:180-188, 2002
Fasano A, Catassi C: Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 120:636-651, 2001
Volta U, Molinaro N, de Franceschi L, Fratangelo D, Bianchi FB: IgA anti-endomysial antibodies on human umbilical cord tissue for celiac disease screening: save both money and monkeys. Dig Dis Sci 40:1902-1905, 1995
Ferreira M, Davies SL, Butler M, Scott D, Clark M, Kumar P: Endomysial antibody: is it the best screening test for celiac disease? Gut 33:1633-1637, 1992
Grodzinsky E, Hed J, Skogh T: IgA antiendomysium antibodies have a high positive predictive value for celiac disease in asymptomatic patients. Allergy 49:593-597, 1994
Lagerqvist C, Ivarsson A, Juto P, Persson LA, Hernell O: Screening for adult celiac disease—Which serological marker(s) to use? J Intern Med 250:241-248, 2001
Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BME, Meijer JWR, Mulder CJJ: Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol 94:888-894, 1999
Uibo O, Uibo R, Kleimola V, Jogi T, Maki M: Serum IgA anti-gliadin antibodies in an adult population sample: high prevalence without celiac disease. Dig Dis Sci 38:2034-2037, 1993
Catassi C, Fanciulli G, D'Appello AR, El Asmar R, Rondina C, Fabiani E, Bearzi I, Coppa GV: Antiendomysium versus antigliadin antibodies in screening the general population for celiac disease. Scand J Gastroenterol 35:732-736, 2000
Sjoberg K, Lindgren S, Eriksson S: Frequent occurrence of non-specific gliadin antibodies in chronic liver disease. Endomysial but not gliadin antibodies predict celiac disease in patients with chronic liver disease. Scand J Gastroenterol 32:1162-1167, 1997
Lindgren S, Sjoberg K, Ericksson S: Unsuspected celiac disease in chronic ‘cryptogenic’ liver disease. Scand J Gastroenterol 29:661-664, 1994
Angulo P, Peter JB, Gershwin ME, DeSotel CK, Shoenfeld Y, Ahmed AEE, Lindor KD: Serum autoantibodies in patients with primary sclerosing cholangitis. J Hepatol 32:182-187, 2000
Lasagni D, Ferrari R, Lapini M: Unmasking anti-endomysial antibodies in celiac subjects positive for anti-smooth muscle antibodies. Acta paediatr 88:462-464, 1999
Logan RFA, Ferguson A, Finlayson NDC, Weir DG: Primary biliary cirrhosis and celiac disease: An association? Lancet 1:230-233, 1978
Olsson R, Kagevi I, Rydberg L: On the occurrence of primary biliary cirrhosis and intestinal villous atrophy. Scand J Gastroenterol 17:625-628, 1982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Al-Osaimi, A.M.S., Berg, C.L. CASE REPORT: Association of Primary Sclerosing Cholangitis and Celiac Disease: A Case Report and Review of the Literature. Dig Dis Sci 49, 438–443 (2004). https://doi.org/10.1023/B:DDAS.0000020499.88546.61
Issue Date:
DOI: https://doi.org/10.1023/B:DDAS.0000020499.88546.61